PHASTAR named as winners of prestigious Queens Award for Enterprise

PHASTAR named as winners of prestigious Queens Award for Enterprise

PHASTAR is delighted to be announced today as winners of the highly coveted Queens Award for Enterprise, in the International Trade category!

PHASTAR’s win was down to its excellence in international trade and its exponential growth from a one-person operation in 2007, to a global CRO with offices in four continents within the space of one decade. PHASTAR’s reputation as a quality provider of statistics, programming and data science services to the pharmaceutical and biotechnology industries now sees it as one of the top 10 data focused CROs worldwide.

The Queens Award, now in its 53rd year, focuses on outstanding achievement by UK businesses in several categories including innovation, international trade and sustainable development, with winning companies invited to a royal reception in Buckingham Palace and receiving an official grant of appointment from one of The Queen’s representatives.

Commenting on the win, Kevin Kane, PHASTAR’s Founder and CEO, stated: “I am so proud of what we as a company have achieved in our ten years in business. PHASTAR’s impressive year on year growth is down to the exceptional quality of our people, our culture and our reputation with our customers. Being announced as winners of the impressive Queens Award for Enterprise is a huge accolade for us and spurs on our ambitious future international growth plans. As founder and CEO of PHASTAR, I am incredibly honoured to take a UK company and build an international business that continues to grow in a highly competitive market”.

PHASTAR has recently increased in foothold in the US with the opening of its Boston office and will continue to diversify its business locations with a keen interest in opening a base in Japan and West Coast US in the next 12 months. PHASTAR currently has ten offices across four continents and its ambitious future growth plans includes doubling its staff numbers in the next four years.